Evidence map›Paper›PMID 34563163›Full record

ArticleBMC public health2021

Performance of existing and novel surveillance case definitions for COVID-19 in household contacts of PCR-confirmed COVID-19.

Hannah E Reses, Mark Fajans, Scott H Lee, Charles M Heilig, Victoria T Chu, Natalie J Thornburg, Kim Christensen, Sanjib Bhattacharyya, Alicia Fry, Aron J Hall and 4 more

Abstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hannah E Reses *COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Mark Fajans *COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Scott H LeeCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Charles M HeiligCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Victoria T ChuCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Natalie J ThornburgCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Kim ChristensenUtah Department of Health, Salt Lake City, UT, USA.
Sanjib BhattacharyyaCity of Milwaukee Health Department, Milwaukee, WI, USA.
Alicia FryCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Aron J HallCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Jacqueline E TateCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Hannah L KirkingCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Scott A NabityCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA. hjq5@cdc.gov.ORCID 0000-0002-0170-5649
U.S. COVID-19 Household Investigation Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOptimized symptom-based COVID-19 case definitions that guide public health surveillance and individual patient management in the community may assist pandemic control.

methodsWe assessed diagnostic performance of existing cases definitions (e.g. influenza-like illness, COVID-like illness) using symptoms reported from 185 household contacts to a PCR-confirmed case of COVID-19 in Wisconsin and Utah, United States. We stratified analyses between adults and children. We also constructed novel case definitions for comparison.

resultsExisting COVID-19 case definitions generally showed high sensitivity (86-96%) but low positive predictive value (PPV) (36-49%; F-1 score 52-63) in this community cohort. Top performing novel symptom combinations included taste or smell dysfunction and improved the balance of sensitivity and PPV (F-1 score 78-80). Performance indicators were generally lower for children (< 18 years of age).

conclusionsExisting COVID-19 case definitions appropriately screened in household contacts with COVID-19. Novel symptom combinations incorporating taste or smell dysfunction as a primary component improved accuracy. Case definitions tailored for children versus adults should be further explored.

Indexed as

COVID-19AdultChildCohort StudiesHumansPandemicsPolymerase Chain ReactionSARS-CoV-2AdultsChildrenCOVID-19Diagnostic accuracyPredictive valuesSARS-CoV-2SensitivitySpecificitySurveillanceSymptomsSyndromic

Identifiers

PMID34563163
PMCPMC8465785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.